Testing a web health app with an AI assistant for chronic conditions
Tests whether an AI-assisted health app is useful and easy to use.
Plain-language title generated from the registry record
Registry title: Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition
Key facts
- Where
- Geneva, SwitzerlandSee the site
Where in Switzerland
- Geneva University Hospitals (HUG), Division of Primary Care MedicineGeneva, SwitzerlandNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondation Net-Care.ch
- Trial code
- NCT07916753
- Record updated
- 6 November 2026
- Original description
The SOFIA study evaluates a web-based health application for people living with one or more chronic conditions. The study aims to find out whether the SOFIA application is useful, easy to use, and used over time by participants.Read full original descriptionShow less
SOFIA: Evaluation of the Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition
The SOFIA study evaluates a web-based health application for people living with one or more chronic conditions. The study aims to find out whether the SOFIA application is useful, easy to use, and used over time by participants.
The SOFIA application offers tools to support the day-to-day management of health: lifestyle challenges, health data entry and personal tracking (e.g., blood pressure, weight), medication tracking for people using pochettes-doses (pharmacy-prepared unit-dose packets), and an AI conversational assistant providing general health information. The application does not make diagnoses, give personalized medical advice, or recommend treatment. It complements usual medical care but does not replace it.
The study first enrolls people with hypertension, then, subject to ethics committee approval, people with type 2 diabetes and obesity.
Participation takes place entirely online, through the SOFIA application, accessible from a web browser (smartphone, tablet, or computer). There are no in-person visits. Participants use the application freely, at their own pace, until the end of the study. Short questionnaires (most take 1 to 3 minutes) are offered in the application during the study, and a final questionnaire (about 20 minutes) at the end.
Inclusion: Aged 18 years or older; Resident or worker in the canton of Geneva; Access to a device with a web browser and internet connection (smartphone, tablet, or computer); Ability to read and understand French sufficiently to use the application and complete study questionnaires; Willing and able to comply with the study procedures; Digital informed consent (e-consent) provided; Self-reported diagnosis of hypertension.
Exclusion: Current participation in another interventional clinical trial; Inability to provide digital informed consent; Participation in the SOFIA beta testing program.